
Incretin Mimetics Market Size
The global incretin mimetics market size was valued at USD 14.15 billion in 2024 and is expected to reach USD 31.90 billion by 2032, at a CAGR of 10.69% during the forecast period
The market growth is largely fueled by the rising prevalence of type 2 diabetes globally, alongside an increasing focus on innovative therapies that offer better glycemic control with reduced side effects. Incretin mimetics, such as GLP-1 receptor agonists, are gaining traction due to their dual benefit of glucose regulation and weight management
𝐕𝐢𝐬𝐢𝐭 𝐮𝐬 𝐧𝐨𝐰 -

